157 related articles for article (PubMed ID: 25050995)
1. Uncertainty and variability in the exposure reconstruction of chemical incidents--the case of acrylonitrile.
Huizer D; Ragas AM; Oldenkamp R; van Rooij JG; Huijbregts MA
Toxicol Lett; 2014 Dec; 231(3):337-43. PubMed ID: 25050995
[TBL] [Abstract][Full Text] [Related]
2. Biomonitoring following a chemical incident with acrylonitrile and ethylene in 2008.
Leng G; Gries W
Toxicol Lett; 2014 Dec; 231(3):360-4. PubMed ID: 24960063
[TBL] [Abstract][Full Text] [Related]
3. Acrylonitrile exposure assessment in the emergency responders of a major train accident in Belgium: a human biomonitoring study.
Van Nieuwenhuyse A; Fierens S; De Smedt T; De Cremer K; Vleminckx C; Mertens B; Van Overmeire I; Bader M; De Paepe P; Göen T; Nemery B; Schettgen T; Stove C; Van Oyen H; Van Loco J
Toxicol Lett; 2014 Dec; 231(3):352-9. PubMed ID: 25128591
[TBL] [Abstract][Full Text] [Related]
4. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
Liao KH; Tan YM; Clewell HJ
Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
[TBL] [Abstract][Full Text] [Related]
5. Acrylonitrile exposure in the general population following a major train accident in Belgium: a human biomonitoring study.
De Smedt T; De Cremer K; Vleminckx C; Fierens S; Mertens B; Van Overmeire I; Bader M; De Paepe P; Göen T; Nemery B; Schettgen T; Stove C; Van Oyen H; Van Loco J; Van Nieuwenhuyse A
Toxicol Lett; 2014 Dec; 231(3):344-51. PubMed ID: 25223249
[TBL] [Abstract][Full Text] [Related]
6. Separating uncertainty and physiological variability in human PBPK modelling: The example of 2-propanol and its metabolite acetone.
Huizer D; Oldenkamp R; Ragas AM; van Rooij JG; Huijbregts MA
Toxicol Lett; 2012 Oct; 214(2):154-65. PubMed ID: 22955064
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in patients admitted to the emergency department after exposure to acrylonitrile in a major railway incident involving bulk chemical material.
Colenbie S; Buylaert W; Stove C; Deschepper E; Vandewoude K; De Smedt T; Bader M; Göen T; Van Nieuwenhuyse A; De Paepe P
Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):261-270. PubMed ID: 28110842
[TBL] [Abstract][Full Text] [Related]
8. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
Tan YM; Liao KH; Conolly RB; Blount BC; Mason AM; Clewell HJ
J Toxicol Environ Health A; 2006 Sep; 69(18):1727-56. PubMed ID: 16864423
[TBL] [Abstract][Full Text] [Related]
9. Follow-up biomonitoring after accidental exposure to acrylonitrile:- implications for protein adducts as a dose monitor for short-term exposures.
Bader M; Wrbitzky R
Toxicol Lett; 2006 Apr; 162(2-3):125-31. PubMed ID: 16280213
[TBL] [Abstract][Full Text] [Related]
10. Reverse dosimetry modeling of toluene exposure concentrations based on biomonitoring levels from the Canadian health measures survey.
Tohon H; Nong A; Moreau M; Valcke M; Haddad S
J Toxicol Environ Health A; 2018; 81(20):1066-1082. PubMed ID: 30365389
[TBL] [Abstract][Full Text] [Related]
11. Biological monitoring to assess dermal exposure to ethylene oxide vapours during an incidental release.
Boogaard PJ; van Puijvelde MJ; Urbanus JH
Toxicol Lett; 2014 Dec; 231(3):387-90. PubMed ID: 24882394
[TBL] [Abstract][Full Text] [Related]
12. Short-term health effects in the general population following a major train accident with acrylonitrile in Belgium.
Simons K; De Smedt T; Stove C; De Paepe P; Bader M; Nemery B; Vleminckx C; De Cremer K; Van Overmeire I; Fierens S; Mertens B; Göen T; Schettgen T; Van Oyen H; Van Loco J; Van Nieuwenhuyse A
Environ Res; 2016 Jul; 148():256-263. PubMed ID: 27085497
[TBL] [Abstract][Full Text] [Related]
13. Testing the coherence between occupational exposure limits for inhalation and their biological limit values with a generalized PBPK-model: the case of 2-propanol and acetone.
Huizer D; Huijbregts MA; van Rooij JG; Ragas AM
Regul Toxicol Pharmacol; 2014 Aug; 69(3):408-15. PubMed ID: 24852492
[TBL] [Abstract][Full Text] [Related]
14. Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbaryl.
Brown K; Phillips M; Grulke C; Yoon M; Young B; McDougall R; Leonard J; Lu J; Lefew W; Tan YM
Regul Toxicol Pharmacol; 2015 Dec; 73(3):689-98. PubMed ID: 26545325
[TBL] [Abstract][Full Text] [Related]
15. Using population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: The example of occupational exposure to styrene.
Verner MA; McDougall R; Johanson G
Toxicol Lett; 2012 Sep; 213(2):299-304. PubMed ID: 22677344
[TBL] [Abstract][Full Text] [Related]
16. Biological exposure indicators: quantification of biological variability using toxicokinetic modeling.
Truchon G; Tardif R; Droz PO; Charest-Tardif G; Pierrehumbert G
J Occup Environ Hyg; 2006 Mar; 3(3):137-43. PubMed ID: 16464817
[TBL] [Abstract][Full Text] [Related]
17. Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling.
Takano R; Murayama N; Horiuchi K; Kitajima M; Kumamoto M; Shono F; Yamazaki H
Regul Toxicol Pharmacol; 2010 Nov; 58(2):252-8. PubMed ID: 20600458
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic model parameter estimation and sensitivity and variability analyses for acrylonitrile disposition in humans.
Sweeney LM; Gargas ML; Strother DE; Kedderis GL
Toxicol Sci; 2003 Jan; 71(1):27-40. PubMed ID: 12520073
[TBL] [Abstract][Full Text] [Related]
19. Human biomonitoring after chemical incidents and during short-term maintenance work as a tool for exposure analysis and assessment.
Bader M; Van Weyenbergh T; Verwerft E; Van Pul J; Lang S; Oberlinner C
Toxicol Lett; 2014 Dec; 231(3):328-36. PubMed ID: 25290578
[TBL] [Abstract][Full Text] [Related]
20. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
Jongeneelen FJ; Berge WF
Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
